C 18 H 16 Cl 2 N4O 2 S, monoclinic, P21/c (no. 14), a = 9.1950 (5) 
T = 296 K.
CCDC no.: 1459025
The crystal structure is shown in the gure. Tables 1 and  2 contain details of the measurement method and a list of the atoms including atomic coordinates and displacement parameters. 
Source of material
The title compound was synthesized from reaction of 5-(2-chloro-5-nitrophenyl)-3-(4-chlorophenyl)-4,5-dihydro-1H-pyrazole with ethyl isothiocyanate in dry ethanol for 2 h under re ux condition. The solid produced was ltered, dried and recrystallized from dimethylformamide to give colourless crystals of the title compound (Mp. 207°C).
Discussion
Compounds possessing pyrazoline ring systems are an important class of heterocycles. Recently, various pyrazoline containing materials with interesting properties were .
synthesized [1] [2] [3] [4] . They have signi cant biological activities including antimicrobial, anticonvulsant and antiviral [5] [6] [7] [8] [9] . The asymmetric unit of the title structure contains one molecule, in which the phenyl ring (C10-C15) is highly deviated from the whole molecule plane and makes a dihedral angle of 78.74(3)°with the pyrazol ring (N1-N2-C7-C8-C9). The packing shows four potential hydrogen bonds: N4-H1N4· · · S1
i , C8-H8A· · · O1 ii , C8-H8B· · · Cl1 iii and C18-H18C· · · N1 iv with symmetry code: (i) x, −y + 3/2, z − 1/2;
(ii) −x + 1, −y + 1, −z + 1; (iii) x, y, z + 1; (iv) x, −y + 3/2, z + 1/2.
